What failure rate are we willing to accept in cell therapy manufacture? Insights from medical device development

Autologous cell therapies hold great promise in the treatment of many cancers but are generally produced using processes and equipment for which there are concerns as to whether they are sufficiently reliable to support scale-out to 1000s of systems. Medical device development holds important lessons for achieving the required reliability for cell therapy automation equipment.

Cell Therapy

We use cookies to improve your experience on our site. To find out more, read our updated privacy policy. More information.